Anti-Human IGF1 Receptor Therapeutic Antibody (Robatumumab)
Recombinant monoclonal antibody to IGF1 Receptor. Robatumumab (proposed INN) is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-209 |
| Pricing | Inquiry |
| Host | Human |
| Target | IGF1 Receptor |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | FuncS, IF, Neut, ELISA, FC, IP, ICC |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |